JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M007706200 on November 13, 2000

J. Biol. Chem., Vol. 276, Issue 8, 5525-5532, February 23, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/8/5525    most recent
M007706200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eyries, M.
Right arrow Articles by Soubrier, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eyries, M.
Right arrow Articles by Soubrier, F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Increased Shedding of Angiotensin-converting Enzyme by a Mutation Identified in the Stalk Region*

Melanie EyriesDagger §, Annie Michaud, Jaap Deinum||, Monique AgrapartDagger , Jacques Chomilier**, Cornelis KramersDagger Dagger , and Florent SoubrierDagger §§

From the Dagger  Institut National de la Santé et de la Recherche Médicale Unit 525, Faculté de médecine Pitié-Salpétrière, 91 Boulevard de l'Hôpital, 75013 Paris, France; the  Unit 36-Collège de France, 3 rue d'Ulm, 75005 Paris, France; the || Department of Internal Medicine I, University of Rotterdam, dr Molewaterplein 40 3015 GD Rotterdam, The Netherlands; the ** Université Paris 6 and 7, CNRS UMR 7590, 4 place Jussieu, 75252 Paris Cedex 05, France; and the Dagger Dagger  Department of Pharmacology and Toxicology and Department of Internal Medicine, University Medical Center Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands

Angiotensin-converting enzyme (ACE), an enzyme that plays a major role in vasoactive peptide metabolism, is a type 1 ectoprotein, which is released from the plasma membrane by a proteolytic cleavage occurring in the stalk sequence adjacent to the membrane anchor. In this study, we have discovered the molecular mechanism underlying the marked increase of plasma ACE levels observed in three unrelated individuals. We have identified a Pro1199 right-arrow Leu mutation in the juxtamembrane stalk region. In vitro analysis revealed that the shedding of [Leu1199]ACE was enhanced compared with wild-type ACE. The solubilization process of [Leu1199]ACE was stimulated by phorbol esters and inhibited by compound 3, an inhibitor of ACE-secretase. The results of Western blot analysis were consistent with a cleavage at the major described site (Arg1203down-arrow Ser1204). Two-dimensional structural analysis of ACE showed that the mutated residue was critical for the positioning of a specific loop containing the cleavage site. We therefore propose that a local conformational modification caused by the Pro1199 right-arrow Leu mutation leads to more accessibility at the stalk region for ACE secretase and is responsible for the enhancement of the cleavage-secretion process. Our results show that different molecular mechanisms are responsible for the common genetic variation of plasma ACE and for its more rare familial elevation.


* This work was supported by INSERM, by a grant from the French Ministry of Research, and by an unrestricted grant from Bristol-Myers-Squibb.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Recipient of a Ph.D. grant from the Société Francaise d'Athérosclérose and the Fondation de France.

§§ To whom correspondence should be addressed: INSERM U525, Faculté de médecine Pitié-Salpétrière, 91, boulevard de l'hôpital, 75013 Paris, France. Tel.: 33-1 40 77 97 25; Fax: 33-1 40 77 97 28; E-mail: florent.soubrier@chups.jussieu.fr.


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Physiol.Home page
A. Watkins, A. Wilkins, C. Osmond, C. M. Warner, M. Comiskey, M. Hanson, and T. P. Fleming
The influence of mouse Ped gene expression on postnatal development
J. Physiol., February 15, 2006; 571(1): 211 - 220.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. L. Tsakadze, S. D. Sithu, U. Sen, W. R. English, G. Murphy, and S. E. D'Souza
Tumor Necrosis Factor-{alpha}-converting Enzyme (TACE/ADAM-17) Mediates the Ectodomain Cleavage of Intercellular Adhesion Molecule-1 (ICAM-1)
J. Biol. Chem., February 10, 2006; 281(6): 3157 - 3164.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. M. Danilov, J. Deinum, I. V. Balyasnikova, Z.-L. Sun, C. Kramers, C. E.M. Hollak, and R. F. Albrecht
Detection of Mutated Angiotensin I-Converting Enzyme by Serum/Plasma Analysis Using a Pair of Monoclonal Antibodies
Clin. Chem., June 1, 2005; 51(6): 1040 - 1043.
[Full Text] [PDF]


Home page
NeurologyHome page
M. Linnebank, K. Kesper, M. Jeub, H. Urbach, U. Wullner, T. Klockgether, and S. Schmidt
Hereditary elevation of angiotensin converting enzyme suggesting neurosarcoidosis
Neurology, December 23, 2003; 61(12): 1819 - 1820.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Gaertner, F. Prunier, M. Philippe, L. Louedec, J.-J. Mercadier, and J.-B. Michel
Scar and pulmonary expression and shedding of ACE in rat myocardial infarction
Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H156 - H164.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Kramers, S. M. Danilov, J. Deinum, I. V. Balyasnikova, N. Scharenborg, M. Looman, F. Boomsma, M. H. de Keijzer, C. van Duijn, S. Martin, et al.
Point Mutation in the Stalk of Angiotensin-Converting Enzyme Causes a Dramatic Increase in Serum Angiotensin-Converting Enzyme But No Cardiovascular Disease
Circulation, September 11, 2001; 104(11): 1236 - 1240.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Alfalah, E. T. Parkin, R. Jacob, E. D. Sturrock, R. Mentele, A. J. Turner, N. M. Hooper, and H. Y. Naim
A Point Mutation in the Juxtamembrane Stalk of Human Angiotensin I-converting Enzyme Invokes the Action of a Distinct Secretase
J. Biol. Chem., June 8, 2001; 276(24): 21105 - 21109.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.